Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

6.720 +0.050 (+0.75%)
Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally. 
Via StockStory
Topics Lawsuit Stocks World Trade
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
Earnings Scheduled For May 8, 2025
 
Via Benzinga
ELV Q1 Deep Dive: Carelon Expansion and Margin Trends in Focus as Guidance Reaffirmed
Health insurance provider Elevance Health (NYSE:EVH) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 13.4% year on year to $49.78 billion. Its non-GAAP profit of... 
Via StockStory
The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts
 
Via Benzinga
Elevance Health (NYSE:ELV) Beats Q2 Sales Targets
Health insurance provider Elevance Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 13.4% year on year to $49.78 billion. Its non-GAAP profit of $8.84 per share was... 
Via StockStory
Elevance Health (ELV) Reports Earnings Tomorrow: What To Expect
Health insurance provider Elevance Health (NYSE:EVH) will be reporting results this Thursday before the bell. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Elevance Health (ELV) Stock Trades Down, Here Is Why
Shares of health insurance provider Elevance Health (NYSE:EVH) fell 11.5% in the afternoon session after the company reported its second-quarter results and cut its full-year profit guidance, citing... 
Via StockStory
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
Stocks making big moves this week: Oscar Health, Sunrun, Elevance Health, Tesla, and GMS
Check out the companies making headlines this week: 
Via StockStory
Topics Electric Vehicles
Why Elevance Health (ELV) Shares Are Sliding Today
Shares of health insurance provider Elevance Health (NYSE:EVH) fell 9.9% in the afternoon session after peer, Centene pulled its full-year financial guidance, triggering a sector-wide sell-off. 
Via StockStory
Topics Artificial Intelligence
UBS Views Evolent Health’s Q2 Outlook And Financing Moves As ‘Incrementally Positive’
The company reaffirmed its full-year adjusted core profit guidance and noted that oncology cost trends remained below forecast through the first two-thirds of the quarter. 
Via Stocktwits
Demystifying Evolent Health: Insights From 5 Analyst Reviews
 
Via Benzinga
3 Russell 2000 Stocks Facing Headwinds
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
EVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic Focus
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 24.4% year on year to $483.6 million. Revenue guidance... 
Via StockStory
Topics Artificial Intelligence
3 Stocks Under $10 in the Doghouse
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as... 
Via StockStory
3 Value Stocks Walking a Fine Line
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +2.0%) as President Trump postponed the planned 50% tariff on European Union imports,... 
Via StockStory
Topics Artificial Intelligence Government Stocks
Reflecting On Healthcare Technology for Providers Stocks’ Q1 Earnings: Evolent Health (NYSE:EVH)
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Evolent Health (NYSE:EVH) and its peers. 
Via StockStory
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that... 
Via StockStory
Topics Bonds Stocks
1 Healthcare Stock to Keep an Eye On and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Economy Stocks
Expert Outlook: Evolent Health Through The Eyes Of 9 Analysts
 
Via Benzinga
Evolent Health (NYSE:EVH) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 24.4% year on year to $483.6 million. Revenue guidance... 
Via StockStory
Evolent Health (EVH) Q1 Earnings Report Preview: What To Look For
Healthcare solutions company Evolent Health (NYSE:EVH) will be announcing earnings results tomorrow after market close. Here’s what investors should know. 
Via StockStory
1 Unprofitable Stock Worth Investigating and 2 to Question
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and... 
Via StockStory
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and... 
Via StockStory
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers. 
Via StockStory
Topics Economy
Elevance Health’s (NYSE:ELV) Q1 Sales Top Estimates
Health insurance provider Elevance Health (NYSE:EVH) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 14.5% year on year to $48.77 billion. Its non-GAAP profit of $11.97... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.